Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Orion Nutraceuticals Inc C.ORI

Orion Nutraceuticals Inc. is a Canada-based company. The Company is primarily focused on re-purposing a United States food and drug administration approved drug to target asthma and chronic obstructive pulmonary disease (COPD).


CSE:ORI - Post by User

Post by SolidInvestmenton Aug 22, 2019 10:04am
142 Views
Post# 30054430

News. Compensation for doing absolutely nothing...

News. Compensation for doing absolutely nothing...Orion CFO Cherry, secretary Urata resign 2019-08-22 02:26 ET - News Release Mr. Jonathan Fiteni reports ORION NUTRACEUTICALS ANNOUNCES RESIGNATIONS OF MANAGEMENT AND SHARES FOR SERVICES Christopher Cherry has resigned as chief financial officer and a director of Orion Nutraceuticals Inc., and Jan Urata has resigned as corporate secretary of the company. The company would like to thank Mr. Cherry and Ms. Urata for their contributions to the company and wishes them well with their future endeavours. The company also announces that it will issue a total of 460,000 common shares of the company at a deemed price of 10 cents per share to Jonathan Fiteni, chief executive officer and a director of the company, for certain consulting services provided to the company owed totalling approximately $46,000. The shares issued to Mr. Fiteni will be subject to a four-month-and-one-day hold period. About Orion Nutraceuticals Inc. Orion Nutraceuticals aims to set a new standard in cannabis life science by producing and developing innovative products with key strategic partners in the industry. In conjunction with its professional sports strategic alliances, the company is poised to advance research and development in the plant science sector, deliver science-based products and services, and market CBD (cannabidiol) therapies to the mainstream with proprietary brands and products. 2019 Canjex Publishing Ltd. All rights reserved.
<< Previous
Bullboard Posts
Next >>